Objective
The National Laboratory of the National Institute of Biostructures and Biosystems (INBB) is recruiting two scientists who will be engaged in:
1) expanding manufacturing facility to provide pre-clinical grade adenovirus (AV), adeno-associated virus (AAV) and lentivirus (LV) vectors for novel gene therapy and
2) harvesting, selecting and enriching endothelial cell progenitors from human peripheral blood. These individuals will be responsible for providing such vectors and cells that will be used to promote therapeutic angiogenesis in animal models of diabetes-induced microangiopathy and peripheral neuropathy. The scientist in charge of gene transfer systems will oversee ongoing viral production and implement new scale up and purification techniques for AAV, AV and other vectors suitable for human tissue kallikrein, NGF, and eNOS transgene delivery. The scientist in charge of endothelial cell progenitors will be responsible of isolation of CD34+ KDR+ cells from human blood in quantities sufficient for in vivo experiments in animal models. Both scientists will need experience in molecular biology, virology, and cell biology. For endothelial cell progenitor program, competence in hematology is required. Both positions require a PhD or at least 4-year post-graduate experience in the above areas. Interested individuals should send resumes to Paolo Madeddu, MD, Prof. of Therapy, Head of Gene Therapy Section of the National Laboratory INBB, Via S. Antonio, 07033 Osilo (SS), Italy. Tel/fax 0039 79 3441006, Email: madeddu@yahoo.com. INBB is a National Consortium of 26 Italian Universities with Laboratory facilities in Northern Sardinia.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences medical biotechnology genetic engineering gene therapy
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences cell biology
- medical and health sciences clinical medicine hematology
- natural sciences biological sciences molecular biology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
07033 OSILO
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.